{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:12:32Z","timestamp":1792131152889,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Each year, over 700,000 pregnancies occur in the UK, with up to 10% affected by complications such as hypertensive disorders of pregnancy and gestational diabetes mellitus. Pregnancy-related complications and reproductive factors are associated with an increased risk of cardiovascular disease (CVD) later in life. Our aim was to determine whether adding pregnancy factors to a prediction model with established CVD risk factors improves 10-year risk prediction of CVD in postpartum women, using QRISK\u00ae-3 as a benchmark model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used a population-based retrospective cohort of women aged 15 to 49 who had been pregnant from the Clinical Practice Research Datalink (CPRD) primary care database. Women who were CVD-free were followed from 6\u00a0months postpartum. We evaluated the performance of QRISK\u00ae-3 and updated the risk prediction model using established risk factors for CVD from QRISK\u00ae-3 and additional risk factors specific to pregnancy. Models were developed using Cox-proportional hazards regression for CVD within 10\u00a0years. Models were evaluated and compared using measures of overall model fit, calibration, discrimination and clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 567,667 eligible women, 2175 (0.38%) experienced a CVD event within 10\u00a0years. The median follow-up was 4\u00a0years. Of the additional pregnancy factors, gestational hypertension, preeclampsia, miscarriage, stillbirth, postnatal depression, gravidity, endometriosis and polycystic ovary syndrome remained associated with CVD after adjusting for other established risk factors of CVD. Adding pregnancy factors to those from QRISK\u00ae-3 led to marginal improvements in model performance (QRISK\u00ae-3\n                      <jats:italic>C<\/jats:italic>\n                      -statistic: 0.703 (95% CI 0.687 to 0.718),\n                      <jats:italic>updated model C-statistic<\/jats:italic>\n                      : 0.726 (95% CI 0.711 to 0.740) Although calibration did not improve overall, subgroup analysis showed better calibration in women with a history of pre-eclampsia, postnatal depression and preterm birth using the updated model. The clinical utility was improved for updated models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The updated risk prediction models resulted in marginal improvement in discrimination and calibration compared to QRISK\u00ae-3 in postpartum women. This could be due to the known association of pregnancy-related complications with established risk factors of CVD. Although the overall predictive performance and calibration of the updated models was similar, the updated model resulted in better clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-025-04229-1","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T13:56:31Z","timestamp":1756475791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development and validation of a postpartum cardiovascular disease risk prediction model in women incorporating reproductive and pregnancy-related predictors"],"prefix":"10.1186","volume":"23","author":[{"given":"Steven","family":"Wambua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca L.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"McCowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnarajah","family":"Nirantharakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym I. E.","family":"Snell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the MuM-PreDiCT Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"1","key":"4229_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.01.027","volume":"241","author":"Y Appelman","year":"2015","unstructured":"Appelman Y, van Rijn BB, Ten Haaf ME, Boersma E, Peters SA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211\u20138.","journal-title":"Atherosclerosis"},{"issue":"1","key":"4229_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"4229_CR3","doi-asserted-by":"publisher","first-page":"j2099","DOI":"10.1136\/bmj.j2099","volume":"357","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099.","journal-title":"BMJ"},{"issue":"18","key":"4229_CR4","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837\u201347.","journal-title":"Circulation"},{"issue":"1","key":"4229_CR5","doi-asserted-by":"publisher","first-page":"e0210329","DOI":"10.1371\/journal.pone.0210329","volume":"14","author":"SJ Baart","year":"2019","unstructured":"Baart SJ, Dam V, Scheres LJJ, Damen J, Spijker R, Schuit E, et al. Cardiovascular risk prediction models for women in the general population: A systematic review. PLoS ONE. 2019;14(1):e0210329.","journal-title":"PLoS ONE"},{"key":"4229_CR6","doi-asserted-by":"publisher","first-page":"i2416","DOI":"10.1136\/bmj.i2416","volume":"353","author":"JA Damen","year":"2016","unstructured":"Damen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ. 2016;353:i2416.","journal-title":"BMJ"},{"issue":"1","key":"4229_CR7","doi-asserted-by":"publisher","first-page":"e0210329","DOI":"10.1371\/journal.pone.0210329","volume":"14","author":"SJ Baart","year":"2019","unstructured":"Baart SJ, Dam V, Scheres LJ, Damen JA, Spijker R, Schuit E, et al. Cardiovascular risk prediction models for women in the general population: a systematic review. PLoS ONE. 2019;14(1):e0210329.","journal-title":"PLoS ONE"},{"issue":"6","key":"4229_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/aje\/kwv309","volume":"183","author":"DM Haas","year":"2016","unstructured":"Haas DM, Ehrenthal DB, Koch MA, Catov JM, Barnes SE, Facco F, et al. Pregnancy as a window to future cardiovascular health: design and implementation of the nuMoM2b Heart Health Study. Am J Epidemiol. 2016;183(6):519\u201330.","journal-title":"Am J Epidemiol"},{"issue":"14","key":"4229_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/eurheartj\/ehy863","volume":"40","author":"AR Markovitz","year":"2019","unstructured":"Markovitz AR, Stuart JJ, Horn J, Williams PL, Rimm EB, Missmer SA, et al. Does pregnancy complication history improve cardiovascular disease risk prediction? Findings from the HUNT study in Norway. Eur Heart J. 2019;40(14):1113\u201320.","journal-title":"Eur Heart J"},{"key":"4229_CR10","doi-asserted-by":"crossref","unstructured":"Saei Ghare Naz M, Sheidaei A, Aflatounian A, Azizi F, Ramezani Tehrani F. Does adding adverse pregnancy outcomes improve the Framingham Cardiovascular Risk Score in women? Data from the Tehran Lipid and Glucose Study. J Am Heart Assoc. 2022;11(2):e022349.","DOI":"10.1161\/JAHA.121.022349"},{"issue":"5","key":"4229_CR11","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/s41591-024-02905-y","volume":"30","author":"J Hippisley-Cox","year":"2024","unstructured":"Hippisley-Cox J, Coupland CAC, Bafadhel M, Russell REK, Sheikh A, Brindle P, et al. Development and validation of a new algorithm for improved cardiovascular risk prediction. Nat Med. 2024;30(5):1440\u20137.","journal-title":"Nat Med"},{"key":"4229_CR12","doi-asserted-by":"publisher","unstructured":"Okoth K, Chandan JS, Marshall T, Thangaratinam S, Thomas GN, Nirantharakumar K, et al. Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review. BMJ. 2020;371:m3502. https:\/\/doi.org\/10.1136\/bmj.m3502.","DOI":"10.1136\/bmj.m3502"},{"issue":"4","key":"4229_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/AOG.0000000000003363","volume":"134","author":"GN Smith","year":"2019","unstructured":"Smith GN, Louis JM, Saade GR. Pregnancy and the postpartum period as an opportunity for cardiovascular risk identification and management. Obstet Gynecol. 2019;134(4):851\u201362.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"4229_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1071\/AH15144","volume":"40","author":"WE Brodribb","year":"2015","unstructured":"Brodribb WE, Mitchell BL, Van Driel ML. Continuity of care in the post partum period: general practitioner experiences with communication. Aust Health Rev. 2015;40(5):484\u20139.","journal-title":"Aust Health Rev"},{"key":"4229_CR15","doi-asserted-by":"publisher","unstructured":"Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. https:\/\/doi.org\/10.1136\/bmj.j2099.","DOI":"10.1136\/bmj.j2099"},{"issue":"1","key":"4229_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41512-022-00137-7","volume":"6","author":"S Wambua","year":"2022","unstructured":"Wambua S, Crowe F, Thangaratinam S, O\u2019Reilly D, McCowan C, Brophy S, et al. Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors. Diagn Progn Res. 2022;6(1):23.","journal-title":"Diagn Progn Res"},{"issue":"6","key":"4229_CR17","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/S2666-7568(21)00088-X","volume":"2","author":"S Livingstone","year":"2021","unstructured":"Livingstone S, Morales DR, Donnan PT, Payne K, Thompson AJ, Youn JH, et al. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. Lancet Healthy Longev. 2021;2(6):e352\u201361.","journal-title":"Lancet Healthy Longev"},{"key":"4229_CR18","unstructured":"GOV.UK. List of ethnic groups [Available from: https:\/\/www.ethnicity-facts-figures.service.gov.uk\/style-guide\/ethnic-groups\/."},{"issue":"1","key":"4229_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12916-023-02794-x","volume":"21","author":"K Okoth","year":"2023","unstructured":"Okoth K, Smith WP, Thomas GN, Nirantharakumar K, Adderley NJ. The association between menstrual cycle characteristics and cardiometabolic outcomes in later life: a retrospective matched cohort study of 704,743 women from the UK. BMC Med. 2023;21(1):104.","journal-title":"BMC Med"},{"issue":"2","key":"4229_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.114.014508","volume":"131","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) the TRIPOD statement. Circulation. 2015;131(2):211\u20139.","journal-title":"Circulation"},{"key":"4229_CR21","doi-asserted-by":"crossref","unstructured":"Sisk R, Sperrin M, Peek N, van Smeden M, Martin GP. Imputation and Missing Indicators for handling missing data in the development and implementation of clinical prediction models: a simulation study. arXiv preprint arXiv:220612295. 2022.","DOI":"10.1177\/09622802231165001"},{"key":"4229_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jclinepi.2020.03.028","volume":"125","author":"M Sperrin","year":"2020","unstructured":"Sperrin M, Martin GP, Sisk R, Peek N. Missing data should be handled differently for prediction than for description or causal explanation. J Clin Epidemiol. 2020;125:183\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"4229_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0962280209105020","volume":"19","author":"PK Andersen","year":"2010","unstructured":"Andersen PK, Pohar PM. Pseudo-observations in survival analysis. Stat Methods Med Res. 2010;19(1):71\u201399.","journal-title":"Stat Methods Med Res"},{"key":"4229_CR24","unstructured":"Ensor J, Snell KI, Martin EC. PMCALPLOT: Stata module to produce calibration plot of prediction model performance. 2023."},{"issue":"1","key":"4229_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/M22-0844","volume":"176","author":"DJ McLernon","year":"2023","unstructured":"McLernon DJ, Giardiello D, Van Calster B, Wynants L, van Geloven N, van Smeden M, et al. Assessing performance and clinical usefulness in prediction models with survival outcomes: practical guidance for Cox proportional hazards models. Ann Intern Med. 2023;176(1):105\u201314.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4229_CR26","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/1536867X1401400403","volume":"14","author":"P Royston","year":"2014","unstructured":"Royston P. Tools for checking calibration of a Cox model in external validation: approach based on individual event probabilities. Stata J. 2014;14(4):738\u201355.","journal-title":"Stata J"},{"key":"4229_CR27","doi-asserted-by":"publisher","unstructured":"Van Geloven N, Giardiello D, Bonneville EF, Teece L, Ramspek CL, van Smeden M, et al. Validation of prediction models in the presence of competing risks: a guide through modern methods. BMJ. 2022;377:e069249. https:\/\/doi.org\/10.1136\/bmj-2021-069249.","DOI":"10.1136\/bmj-2021-069249"},{"issue":"6","key":"4229_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models. Med Decis Making. 2006;26(6):565\u201374.","journal-title":"Med Decis Making"},{"key":"4229_CR29","doi-asserted-by":"publisher","unstructured":"Vickers AJ, Van Calster B, Steyerberg EW. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ. 2016;352:i6. https:\/\/doi.org\/10.1136\/bmj.i6.","DOI":"10.1136\/bmj.i6"},{"issue":"3","key":"4229_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/bimj.201800240","volume":"62","author":"RM Pfeiffer","year":"2020","unstructured":"Pfeiffer RM, Gail MH. Estimating the decision curve and its precision from three study designs. Biometr J. 2020;62(3):764\u201376.","journal-title":"Biometr J"},{"key":"4229_CR31","unstructured":"Guideline CG181 N. Cardiovascular disease: risk assessment and reduction, including lipid modification. Methods. 2023."},{"key":"4229_CR32","doi-asserted-by":"crossref","unstructured":"Riley RD, van der Windt D, Croft P, Moons KG. Prognosis research in healthcare: concepts, methods, and impact. 1st ed. Oxford: Oxford University Press; 2019.","DOI":"10.1093\/med\/9780198796619.003.0001"},{"key":"4229_CR33","doi-asserted-by":"publisher","unstructured":"Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604. https:\/\/doi.org\/10.1136\/bmj.b604.","DOI":"10.1136\/bmj.b604"},{"issue":"7","key":"4229_CR34","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/sim.6782","volume":"35","author":"M Pavlou","year":"2016","unstructured":"Pavlou M, Ambler G, Seaman S, De Iorio M, Omar RZ. Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events. Stat Med. 2016;35(7):1159\u201377","journal-title":"Stat Med"},{"key":"4229_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jclinepi.2020.12.005","volume":"132","author":"RD Riley","year":"2021","unstructured":"Riley RD, Snell KI, Martin GP, Whittle R, Archer L, Sperrin M, et al. Penalization and shrinkage methods produced unreliable clinical prediction models especially when sample size was small. J Clin Epidemiol. 2021;132:88\u201396.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"4229_CR36","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE Jr, Moons KG, et al. Minimum sample size for developing a multivariable prediction model: PART II-binary and time-to-event outcomes. Stat Med. 2019;38(7):1276\u201396.","journal-title":"Stat Med"},{"key":"4229_CR37","doi-asserted-by":"publisher","unstructured":"Riley RD, Ensor J, Snell KI, Harrell FE, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m441. https:\/\/doi.org\/10.1136\/bmj.m441.","DOI":"10.1136\/bmj.m441"},{"key":"4229_CR38","unstructured":"Rubin DB. Multiple imputation. Flexible imputation of missing data, second edition: Chapman and Hall\/CRC; 2018. p. 29\u201362."},{"key":"4229_CR39","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.","journal-title":"BMJ"},{"issue":"11","key":"4229_CR40","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.jacc.2018.05.077","volume":"72","author":"JJ Stuart","year":"2018","unstructured":"Stuart JJ, Tanz LJ, Cook NR, Spiegelman D, Missmer SA, Rimm EB, et al. Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction. J Am Coll Cardiol. 2018;72(11):1252\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"4229_CR41","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10654-018-0429-1","volume":"33","author":"S Timpka","year":"2018","unstructured":"Timpka S, Fraser A, Schyman T, Stuart JJ, \u00c5svold BO, Mogren I, et al. The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women. Eur J Epidemiol. 2018;33:1003\u201310.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"4229_CR42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/2047487317693949","volume":"24","author":"R Selmer","year":"2017","unstructured":"Selmer R, Igland J, Ariansen I, Tverdal A, Nj\u00f8lstad I, Furu K, et al. NORRISK 2: a Norwegian risk model for acute cerebral stroke and myocardial infarction. Eur J Prev Cardiol. 2017;24(7):773\u201382.","journal-title":"Eur J Prev Cardiol"},{"key":"4229_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s40471-019-00208-2","volume":"6","author":"OS Gunnarsson","year":"2019","unstructured":"Gunnarsson OS, Timpka S. Pregnancy complication history in 10-year cardiovascular disease risk prediction: a review of recent evidence. Current Epidemiology Reports. 2019;6:321\u20138.","journal-title":"Current Epidemiology Reports"},{"issue":"12","key":"4229_CR44","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1177\/2047487319879791","volume":"27","author":"K Moe","year":"2020","unstructured":"Moe K, Sugulle M, Dechend R, Staff AC. Risk prediction of maternal cardiovascular disease one year after hypertensive pregnancy complications or gestational diabetes mellitus. Eur J Prev Cardiol. 2020;27(12):1273\u201383.","journal-title":"Eur J Prev Cardiol"},{"issue":"20","key":"4229_CR45","doi-asserted-by":"publisher","first-page":"e017328","DOI":"10.1161\/JAHA.120.017328","volume":"9","author":"UV Ukah","year":"2020","unstructured":"Ukah UV, Dayan N, Auger N, He S, Platt RW. Development and Internal Validation of a Model Predicting Premature Cardiovascular Disease Among Women With Hypertensive Disorders of Pregnancy: A Population-Based Study in Quebec, Canada. J Am Heart Assoc. 2020;9(20):e017328.","journal-title":"J Am Heart Assoc"},{"key":"4229_CR46","unstructured":"Grandi SM, Filion KB, Hutcheon JA, Smith GN, Platt RW. Development and Validation of a Risk Prediction Model for Cardiovascular Disease in Women of Reproductive Age. Circulation. 2019;140(Suppl_1):A15059-A."},{"issue":"13","key":"4229_CR47","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/sim.9717","volume":"42","author":"N Hartman","year":"2023","unstructured":"Hartman N, Kim S, He K, Kalbfleisch JD. Pitfalls of the concordance index for survival outcomes. Stat Med. 2023;42(13):2179\u201390.","journal-title":"Stat Med"},{"key":"4229_CR48","doi-asserted-by":"publisher","unstructured":"Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, et al. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ. 2017;358:j3078. https:\/\/doi.org\/10.1136\/bmj.j3078.","DOI":"10.1136\/bmj.j3078"},{"issue":"19","key":"4229_CR49","first-page":"1901","volume":"79","author":"JJ Stuart","year":"2022","unstructured":"Stuart JJ, Tanz LJ, Rimm EB, Spiegelman D, Missmer SA, Mukamal KJ, et al. Cardiovascular risk factors mediate the long-term maternal risk associated with hypertensive disorders of pregnancy. J Am Heart Assoc. 2022;79(19):1901\u201313.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"4229_CR50","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1210\/jc.2006-0594","volume":"91","author":"JB Meigs","year":"2006","unstructured":"Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91(8):2906\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4229_CR51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/hr.2010.9","volume":"33","author":"V Kotsis","year":"2010","unstructured":"Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. Mechanisms of obesity-induced hypertension. Hypertens Res. 2010;33(5):386\u201393.","journal-title":"Hypertens Res"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04229-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04229-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04229-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:32:14Z","timestamp":1757482334000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04229-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4229"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04229-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CPRD has ethics approval from the Health Research Authority to support research using anonymized patient data. This study protocol has been submitted to CPRD for approval by Independent Scientific Advisory Committee for CPRD. Protocol number: 22_001909.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"As the study data are de-identified, consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"508"}}